No correlation between suppressor cell function and disease activity in natural history studies of patients with systemic lupus erythematosus
Rautenstrauch, H.; Frank, F.; Saal, J.G.
Zeitschrift für Rheumatologie 44(3): 133-136
1985
ISSN/ISBN: 0340-1855 PMID: 2932868 Document Number: 255376
In ten patients with systemic lupus erythematosus lymphocyte suppressor cell function was repeatedly monitored over a period of nine months. The method used is based on the finding that in vitro addition of ConA to PWM-stimulated lymphocytes activates suppressor T cells which in turn inhibit immunoglobulin synthesis. Nine of ten SLE patients exhibited significant impairment of IgG suppression but no correlation was found between the outcome of the IgG suppressor cell assay and disease activity or the treatment protocol applied.
Document emailed within 1 workday
Related Documents
Hafez, S.S.; Saad, W.E.S.; Shedid, N.H. 2014: B-cell-attracting chemokine-1 (BCA-1/CXCL13) in systemic lupus erythematosus, its correlation to disease activity and renal involvement Egyptian Journal of Immunology 21(2): 23-32Chen, W.-y.; Li, G.-r.; Fang, F.; Yang, X.; He, X.-s.; Zhou, F.-y.; Yu, X.-q. 2004: The expression of migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity in systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 43(8): 572-575
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Leaños-Miranda, A.; Pascoe-Lira, D.; Chávez-Rueda, K.A.; Blanco-Favela, F. 2001: Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity Journal of Rheumatology 28(7): 1546-1553
Katz, P.; Zaytoun, A.M.; Lee, J.H.; Panush, R.S.; Longley, S. 1982: Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event Journal of Immunology 129(5): 1966-1971
Witt, C.; Neuhaus, K.; Winsel, K.; Brenke, A.; Hiepe, F.; Volk, H.D. 1991: Bronchoalveolar lavage in patients with systemic scleroderma and systemic lupus erythematosus: characterization of cell activity by cytofluorometry, chemiluminescence and differential cell count Zeitschrift für Erkrankungen der Atmungsorgane 176(1): 21-29
Greco, C.M.; Rudy, T.E.; Manzi, S. 2004: Effects of disease activity, pain, and distress on activity limitations in patients with systemic lupus erythematosus Journal of Rheumatology 31(2): 260-267
Tomii, M. 1981: Anti-DNA activity in Raji cell eluates of sera from patients with systemic lupus erythematosus Ryumachi 21 Suppl: 123-127
Bhandari, B.; Pal, A.; Maulik, S.; Chakraborti, S. 2012: Lupus glomerulonephritis: a clinicopathological correlation of 93 patients of systemic lupus erythematosus for a follow-up period of three years Journal of the Indian Medical Association 110(10): 710-714
Lit, L.C.-W.; Wong, C.-K.; Li, E.K.-M.; Tam, L.-S.; Lam, C.W.-K.; Lo, Y.-M.D. 2007: Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus Journal of Rheumatology 34(1): 89-96
Xavier, R.M.; Nakamura, M.; Tsunematsu, T. 1994: Isolation and characterization of a human nonspecific suppressor factor from ascitic fluid of systemic lupus erythematosus. Evidence for a human counterpart of the monoclonal nonspecific suppressor factor and relationship to the T cell receptor alpha-chain Journal of Immunology 152(5): 2624-2632
Morimoto, C.; Sano, H.; Abe, T.; Homma, M.; Steinberg, A.D. 1982: Correlation between clinical activity of systemic lupus erythematosus and the amounts of DNA in DNA/anti-DNA antibody immune complexes Journal of Immunology 129(5): 1960-1965
Sumethkul, K.; Srivitidkul, S. 2017: Prevalence of Chronic Hepatitis B Infection in Patients with Systemic Lupus Erythematosus: Viral Reactivation and Impact on Disease Activity Journal of the Medical Association of Thailand 100(Suppl 1): S124-S130
Gheita, T.A.; Abdel Rehim, D.M.; Kenawy, S.A.; Gheita, H.A. 2015: Clinical significance of matrix metalloproteinase-3 in systemic lupus erythematosus patients: a potential biomarker for disease activity and damage Acta Reumatologica Portuguesa 40(2): 145-149
Garcia-Ameijeiras, A.; Gladman, D.D.; Chan, J.Y.; Volpé, R. 1993: Studies of restriction fragment length polymorphism (RFLP) of DR and DQ genes in HLA-DR3 positive patients with Graves' disease or systemic lupus erythematosus Clinical and Investigative Medicine 16(5): 326-332
Di, W.; Pan, J.X.; Hong, S.Y. 1994: Correlation between outcome of pregnancy and condition of disease at conception in systemic lupus erythematosus women Zhonghua Fu Chan Ke Za Zhi 29(7): 414-416; 445-446
Cárdenas-Mondragón, G.; Ulloa-Aguirre, A.; Isordia-Salas, I.; Goffin, V.; Leaños-Miranda, A. 2007: Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays Journal of Rheumatology 34(7): 1514-1521
Adu, D.; Williams, D.G.; Taube, D.; Vilches, A.R.; Turner, D.R.; Cameron, J.S.; Ogg, C.S. 1983: Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis Quarterly Journal of Medicine 52(208): 471-487
Merola, J.F.; Chang, C.A.; Sanchez, M.R.; Prystowsky, S.D. 2011: Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? Journal of Drugs in Dermatology: Jdd 10(12): 1413-1420
Caligaris-Cappio, F.; Bertero, M.T.; Converso, M.; Stacchini, A.; Vinante, F.; Romagnani, S.; Pizzolo, G. 1995: Circulating levels of soluble CD30, a marker of cells producing Th2-type cytokines, are increased in patients with systemic lupus erythematosus and correlate with disease activity Clinical and Experimental Rheumatology 13(3): 339-343